Recent Updates
Recently added Catalysts

TCG Crossover Management, LLC

Track TCG Crossover Management, LLC's latest SEC 13F filing: top biotech and life-sciences stock positions, portfolio weights, largest holdings, and quarter-over-quarter changes.
Updated quarterly · Last refreshed Jun 19, 2026
Showing 6 Stocks Out Of 49. Click On The Tickers For More Details
Stock Compnay Name Shares Held Market Value % of Portfolio QoQ Change
LQDA
LQDA
LIQUIDIA TECHNOLOGIES INC
403.05 K
15.21 M
0.4
IPSC
IPSC
CENTURY THERAPEUTICS INC
17.75 M
39.02 M
1.1
TECX
TECX
TECTONIC THERAPEUTIC INC
1.20 M
37.24 M
1.1
CATX
CATX
PERSPECTIVE THERAPEUTICS INC
7.92 M
33.01 M
0.9
XNCR
XNCR
XENCOR INC
2.45 M
29.57 M
0.8
TRDA
TRDA
ENTRADA THERAPEUTICS INC
2.29 M
28.87 M
0.8
API Access

Simple Pricing, Powerful Insights

Full access to Biotech/Pharma investing and trading opportunities.

No hidden fees, powerful insights, tools, and exclusive real time data to maximize your biotech profits.

yearly_arrow
For Visitors

Preview only and discover why serious investors choose our Premium Plan for comprehensive data.

$0.00 / Month

  • Includes 3 day Elite access
For Serious Investor and Traders
Recommended

Your Key to Consistent Profits: Save Big with Our Annual Plan at Just $19.00 per Month

Only $24.00/ Month

  • Searchable FDA Calendar with 1000+ catalysts like clinical readouts and PDUFA
  • Full access to drug pipelines and company health for informed decisions
  • Probability of Approval (PoA) score cards for each asset
  • Download all data in Excel for your models
  • Historical FDA decisions to shape strategic plans
  • Track biotech earnings and critical catalyst events
  • Monitor insider trading and hedge fund holdings for market insights
  • Options flow and strategy modules (screeners and playbooks)
  • Advanced portfolio tools for smart biotech investments
  • Research on 1,100+ companies and clinical trials
  • Real-time market updates, trends, and analysis
  • Live news feed with customizable alerts (tickers, drugs, indications)
  • Exclusive courses on biotech investment basics
Market Value

$ 3.50 B

Holdings

49

Period

Q1 2026

Holdings in Top 20

82.4 %

QoQ Changes

15.68 %

Top 20 Holdings